The China Daily Business Weekly has reported a number of importantdevelopments in China's Hubei province. The city of Wuxue is to establish a major pharmaceuticals production base, with three large and 20 small production companies, and 3 billion renminbi ($360.6 million) of annual output value.
Also, Huanggang is to establish a new wholesale market for the trading of pharmaceuticals. Some locally-produced drugs could be exported to Hong Kong via the new Beijing-Kowloon railway.
Finally, the Huangjinqiao Economic, Science and Technology Development Zone in Macheng is seeking foreign investment for the construction of export-oriented pharmaceutical and medicinal materials in the zone. Foreign investors could benefit from preferential taxes and other financial incentives.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze